{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:22:30Z","timestamp":1787844150232,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.yebeh.2019.106876","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T22:53:38Z","timestamp":1579128818000},"page":"106876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"PA","title":["Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies"],"prefix":"10.1016","volume":"104","author":[{"given":"J. Eric","family":"Pi\u00f1a-Garza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Patten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.106876_bb0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5698\/1535-7511-12.4s.22","article-title":"AED treatment through different ages: as our brains change, should our drug choices also?","volume":"12","author":"French","year":"2012","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2019.106876_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1528-1157.42.s8.6.x","article-title":"Special needs of the adolescent with epilepsy","volume":"42","author":"Nordli","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106876_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5698\/1535-7511-12.4s.13","article-title":"Transition from pediatric to adult epilepsy care: a difficult process marked by medical and social crisis","volume":"12","author":"Camfield","year":"2012","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2019.106876_bb0020","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1528-1167.2006.00894.x","article-title":"Seizures and antiepileptic drugs: does exposure alter normal brain development?","volume":"47","author":"Marsh","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106876_bb0025","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1212\/01.CON.0000431382.06438.cd","article-title":"Epilepsy and neuropsychological comorbidities","volume":"19","author":"Rudzinski","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2019.106876_bb0030","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199002083220604","article-title":"Phenobarbital for febrile seizures\u2014effects on intelligence and on seizure recurrence","volume":"322","author":"Farwell","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2019.106876_bb0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1440-1754.2003.00180.x","article-title":"Tolerability of topiramate in children and adolescents","volume":"39","author":"Reith","year":"2003","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.yebeh.2019.106876_bb0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/pr.115.012021","article-title":"Epilepsy, antiepileptic drugs, and aggression: an evidence-based review","volume":"68","author":"Brodie","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.yebeh.2019.106876_bb0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejpn.2015.02.008","article-title":"Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study","volume":"19","author":"Rosenfeld","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.106876_bb0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1684\/epd.2016.0871","article-title":"Antiepileptic drug adherence and persistence in children with epilepsy attending a large tertiary care children's hospital","volume":"18","author":"Lee","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2019.106876_bb0055","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/seiz.2000.0470","article-title":"Compliance with health regimens of adolescents with epilepsy","volume":"9","author":"Kyng\u00e4s","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.106876_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008312.pub2","article-title":"Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy","author":"Al-Aqeel","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2019.106876_bb0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.seizure.2005.05.003","article-title":"Drug compliance of children and adolescents with epilepsy","volume":"14","author":"Asadi-Pooya","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.106876_bb0070","first-page":"220","article-title":"Social aspects of epilepsy in childhood and adolescence","volume":"24","author":"Buchanan","year":"1988","journal-title":"Aust Paediatr J"},{"key":"10.1016\/j.yebeh.2019.106876_bb0075","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.1989.03420220087032","article-title":"How often is medication taken as prescribed? A novel assessment technique","volume":"261","author":"Cramer","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2019.106876_bb0080","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1525-5050(02)00037-9","article-title":"The relationship between poor medication compliance and seizures","volume":"3","author":"Cramer","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106876_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/ebeh.2000.0027","article-title":"Impact of taking antiepileptic drugs at school in a group of children and adolescents","volume":"1","author":"Anderson","year":"2000","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106876_bb0090","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.yebeh.2019.106876_bb0095","author":"Food and Drug Administration (FDA)"},{"key":"10.1016\/j.yebeh.2019.106876_bb0100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e3182635735","article-title":"Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304","volume":"79","author":"French","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.106876_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1528-1167.2012.03638.x","article-title":"Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305","volume":"54","author":"French","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106876_bb0110","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.106876_bb0115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/ane.12883","article-title":"Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study","volume":"137","author":"Nishida","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2019.106876_bb0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/epi.13279","article-title":"Cognitive effects of adjunctive perampanel for partial-onset seizures: a randomized trial","volume":"57","author":"Meador","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106876_bb0125","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: a randomized trial","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.106876_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yebeh.2018.03.029","article-title":"Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures","volume":"83","author":"Pi\u00f1a-Garza","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106876_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phrs.2012.12.006","article-title":"Novel treatment options for epilepsy: focus on perampanel","volume":"70","author":"Franco","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.yebeh.2019.106876_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12865","article-title":"The clinical pharmacology profile of the new antiepileptic drug perampanel: a novel noncompetitive AMPA receptor antagonist","volume":"56","author":"Patsalos","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106876_bb0145","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1212\/WNL.0000000000001558","article-title":"Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsy","volume":"84","author":"Gidal","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.106876_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.eplepsyres.2015.09.002","article-title":"Analysis of pooled phase III trials of adjunctive perampanel for epilepsy: impact of mechanism of action and pharmacokinetics on clinical outcomes","volume":"117","author":"Kwan","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.106876_bb0155","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ane.12874","article-title":"Pharmacokinetic\/pharmacodynamic analysis of adjunctive perampanel in subjects with partial-onset seizures","volume":"137","author":"Takenaka","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2019.106876_bb0175","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/epi.12212","article-title":"Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies","volume":"54","author":"Steinhoff","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106876_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.seizure.2006.02.013","article-title":"Cognitive side effects of anti-epileptic drugs. The relevance in childhood epilepsy","volume":"15","author":"Lagae","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.106876_bb0165","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/epi.13417","article-title":"Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: a randomized study evaluating behavior, efficacy, and safety","volume":"57","author":"Lagae","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106876_bb0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1059-1311(97)80060-X","article-title":"Factors influencing compliance with antiepileptic drug regimes","volume":"6","author":"Buck","year":"1997","journal-title":"Seizure"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019308091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019308091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:30:56Z","timestamp":1761503456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019308091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":35,"alternative-id":["S1525505019308091"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106876","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106876"}}